We invite you to read LINO’s latest overview of European policy developments, funding opportunities, and collaboration initiatives in the field of rare diseases.
Rare diseases are becoming an increasingly important priority within the European research and innovation agenda. As policymakers place greater emphasis on this field, new investments in research and innovation continue to emerge. European Commission initiatives, expanding funding opportunities, and international partnerships are creating new possibilities for Lithuanian researchers, healthcare organisations, and businesses to participate in international projects and contribute to the development of innovative diagnostic and treatment solutions. This overview highlights the latest policy developments, key funding instruments, and opportunities available to Lithuania’s research and innovation community.
